Related Experiment Video
Updated: Dec 14, 2025

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
3.8K
Occult Pathologic Findings in Reduction Mammaplasty in 5781 Patients-An International Multicenter Study
Britta Kuehlmann1,2, Florian D Vogl3, Tomas Kempny4
1Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, CA 94305, USA.
Journal of Clinical Medicine
|July 17, 2020
Summary
Reduction mammaplasty (RM) tissue samples revealed unexpected, early-stage breast cancer in some patients. Routine preoperative imaging for RM candidates, especially those with risk factors, is recommended for early detection and treatment.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Breast cancer is a leading global cancer diagnosis, often detected at later stages.
- Reduction mammaplasty (RM) is a common procedure, generating significant tissue samples.
- Occult breast cancer findings in RM tissue offer insights into early disease development.
Purpose of the Study:
- To investigate occult breast cancer findings in a large cohort of reduction mammaplasty samples.
- To assess the value of histopathological examination of RM specimens.
- To recommend strategies for early breast cancer detection in RM patients.
Main Methods:
- Retrospective analysis of over 5000 reduction mammaplasty tissue samples.
- Multi-institutional European cohort study across 16 institutions.
- Histopathological examination of resected breast tissue specimens.
Main Results:
- A significant number of occult breast cancer findings were identified in RM samples.
- While most specimens were benign, unexpected malignancies were detected.
- The study highlights the potential for early cancer detection through routine examination.
Conclusions:
- Histopathological examination of reduction mammaplasty specimens is crucial for detecting occult breast cancer.
- Routine preoperative imaging for RM patients, particularly those with risk factors, is advised.
- Early identification enables a primary oncologic approach, improving patient outcomes.

